Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04OMK
|
|||
| Former ID |
DNC010429
|
|||
| Drug Name |
Nicotinaldehyde O-4-butoxyphenylcarbamoyl oxime
|
|||
| Synonyms |
CHEMBL597445; nicotinaldehyde O-4-butoxyphenylcarbamoyl oxime
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H19N3O3
|
|||
| Canonical SMILES |
CCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CN=CC=C2
|
|||
| InChI |
1S/C17H19N3O3/c1-2-3-11-22-16-8-6-15(7-9-16)20-17(21)23-19-13-14-5-4-10-18-12-14/h4-10,12-13H,2-3,11H2,1H3,(H,20,21)/b19-13+
|
|||
| InChIKey |
GPBQAYXYNOXDEZ-CPNJWEJPSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.